Pharmaceutical Capsule Idra21 Powder Raw Material Idra21 Powder Idra21

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: Dsung-Idra21
• Product Name: Idra21
• Name: Idra21 Powder
• Appearance: White Powder
• Color: White Color
• Assay: HPLC 99%
• Specific: COA
• Test Method: HPLC UV
• Application: Nootropics
• Grade: Pharmaceutical Grade
• CAS: 22503-72-6
• Mf: C8h9cln2o2s
• Melting Point: 209 C Acetic Acid
• Boiling Point: 405.1 Cat760mmhg
• Refractive Index: 1.571
• Density: 1.394
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 500kg/Month

Product Description

Pharmaceutical Capsule Idra21 Powder Raw Material  Idra21 Powder Idra21

Product Description

Product Datails

Product Name	Idra21
Appearance	powder
cas	22503-72-6
Assay	99%
Shelf life	2 years

IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by orscopolamine,and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain. IDRA-21 does not produce neurotoxicity under normal conditions,although it may worsen neuronal damage following global ischemia after stroke or seizures. In comparison to the benzoylpiperidine derived ampakine drugs, IDRA-21 was more potent than CX-516, but less potent than CX-546. Newer benzothiadiazide derivatives with greatly increased potency compared to IDRA-21 have been developed,but these have not been researched to the same extent, with the benzoylpiperidine and benzoylpyrrolidine CX-series of drugs being favoured for clinical development, most likely due to more favourable toxicity profiles at high doses.

Application&Function

Function of Idra21
1.Idra-21 can Increases in cognition
2.Idra-21 can Increased Task Accuracy
3.Idra-21 can Increases in Short Term Memory
4.Idra-21 can Potential Therapeutic Effects On Depression
5.Idra-21 can Neuroprotection 6.Idra-21 can Potential Therapeutic Effects On Schizophrenia
Application of Idra21
It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by scopolamine, and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.

Specification